Trials / Completed
CompletedNCT00960245
Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
A Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the relative bioavailability of Nadolol (1 x 80 mg) tablets under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nadolol (1 x 80 mg) Tablets (Invamed, Inc) | |
| DRUG | Corgard (1 x 80 mg) Tablets (Bristol Laboratories) |
Timeline
- Start date
- 1994-07-01
- Primary completion
- 1994-07-01
- Completion
- 1994-07-01
- First posted
- 2009-08-17
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00960245. Inclusion in this directory is not an endorsement.